METASTATIC UVEAL MELANOMA
Clinical trials for METASTATIC UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on rare eye cancer shows promise in early trial
Disease control Recruiting nowThis study tests a two-step treatment for people with a rare eye cancer (uveal melanoma) that has spread only to the liver. First, a drug is delivered directly to the liver through a special procedure, then an immunotherapy is given to help the immune system attack the cancer. Th…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 17, 2026 04:40 UTC
-
Spinal immunotherapy injection shows promise for tough brain cancers
Disease control Recruiting nowThis early-phase study tests a combination of two ways to give the immunotherapy drug nivolumab: through a vein and directly into the fluid around the spine. It is for people with melanoma or lung cancer that has spread to the lining of the brain or spinal cord (leptomeningeal di…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy targets liver tumors from eye cancer
Disease control Recruiting nowThis study tests whether combining a targeted immunotherapy (tebentafusp) with a liver-directed radiation procedure (Y-90 radioembolization) can help control metastatic uveal melanoma that has spread to the liver. About 30 adults whose cancer is mainly in the liver will receive b…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug targets rare genetic cancers in early trial
Disease control Recruiting nowThis study tests a new drug called IDE196 in people with certain cancers that have specific gene mutations (GNAQ/11 or PRKC fusions), including metastatic uveal melanoma and colorectal cancer. The trial has two phases: first to find safe doses, then to see if the drug shrinks tum…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for rare eye cancer: experimental combo takes on standard therapy
Disease control Recruiting nowThis study tests whether a new drug called RP2, given with nivolumab, works better than the standard combo of ipilimumab and nivolumab for people with metastatic uveal melanoma (eye cancer that has spread). About 280 adults who haven't had immune therapy before will receive injec…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2, PHASE3 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New combo therapy targets eye cancer in the liver
Disease control Recruiting nowThis study tests a drug called tebentafusp combined with treatments directed at the liver for people with a rare eye cancer (uveal melanoma) that has spread to the liver. About 109 adults with a specific genetic type (HLA-A*0201) will participate. The goal is to see if the combin…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New drug cocktail aims to shrink deadly eye cancer tumors
Disease control Recruiting nowThis study tests whether combining two drugs, cemiplimab and ziv-aflibercept, can shrink or stop the growth of metastatic uveal melanoma—a rare eye cancer that has spread to other parts of the body. About 32 adults with this condition will receive the treatment to see if it is sa…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Your own tumor cells may be the key to fighting advanced cancers
Disease control Recruiting nowThis early-stage trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes, or TILs) for people with advanced uveal melanoma (an eye cancer) or certain sarcomas (soft tissue cancers). About 30 participants will have their tumor removed, immune…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
New pill shows promise for rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX for people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink tumors or slow the cancer. About…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated May 01, 2026 15:59 UTC